Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution

SIMPLE SUMMARY: Breast cancer is the most common cancer in women. Approximately 15% of breast cancers harbour an amplification of the ERBB2 gene and/or an overexpression of the HER2 protein and are thus classified as HER2-positive. However, HER2 protein expression could be heterogeneous, showing dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliano, Federica, Carnevale Schianca, Ambra, Corti, Chiara, Ivanova, Mariia, Bianco, Nadia, Dellapasqua, Silvia, Criscitiello, Carmen, Fusco, Nicola, Curigliano, Giuseppe, Munzone, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000152/
https://www.ncbi.nlm.nih.gov/pubmed/36900178
http://dx.doi.org/10.3390/cancers15051385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000152/
https://www.ncbi.nlm.nih.gov/pubmed/36900178
http://dx.doi.org/10.3390/cancers15051385

Ejemplares similares